Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.
Sun Pharma is the fifth largest generic pharmaceutical company in the world. It is also Indias largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high-quality medicines trusted by customers and patients in over 150 countries and has multiple manufacturing facilities and R & D centres. Our leadership is approachable, recognizes peoples passion for growth, gives them a voice and empowers them to make a positive change. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Dadra, U.T. of D. & N. H.(Near Silvassa & Vapi).
Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. (as per IMS Health India, Secondary Stockiest Audit (SSA), Nov 16, 2016 MAT).
Sun Pharma is the fifth largest generic pharmaceutical company in the world. It is also Indias largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high-quality medicines trusted by customers and patients in over 150 countries and has multiple manufacturing facilities and R & D centres. Our leadership is approachable, recognizes peoples passion for growth, gives them a voice and empowers them to make a positive change.
Ajanta Pharma Limited, a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Ajanta operates 7 state-of-the-art manufacturing facilities in India and Mauritius. 2 of the facilities in Lidia have been successfully approved by US FDA. We are looking for competent young professionals to be an integral part of our team for Formulations site at Paithan, near Aurangabad (Maharashtra).
ALEOR Dermaceuticals Ltd, is a joint venture of "Alembic and Orbicular” to develop and commercialize dermatology products for global markets, requires suitable candidates for its Dermaceuticals formulation manufacturing facility at Karakhadi, Padra, Vadodara, Gujarat.
Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.
Otsuka Pharmaceutical India Private Limited primarily manufacture & market products across multiple markets and therapeutic segments To keep pace with our growth plans we require young and skilled employees with experience in Parenteral/ Injectabie formulation for our manufacturing facility in Ahmedabad, Gujarat in the following areas.
Macleods, India's fastest growing pharmaceutical company, with manufacturing sites approved by USFDA & WHO Geneva, ranked among the top pharmaceutical companies with strength of 12,000 employees, operating 60 + countries worldwide, required talented professionals for API PLANT AT SARIGAM.
Par is a pharmaceutical company that develops, manufacturers and markets safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life. Par Pharmaceutical offers a line of high-barrier-to- entry generic drugs. We offer a wide variety of interesting employment opportunities and are continually looking for key external talent to complement our existing workforce and enhance our organizational strength, adding the diversity required to continue along our successful path.